Covaxin
Expert Committee recommends Covaxin for children, DCGI nod awaited
The vaccine manufacturer had completed the Phase 2/3 trials of Covaxin for use in children under 18 years of age in mid-September
WHO to decide on Bharat Biotech's Covaxin emergency usage in October
The duration of the emergency use listing process depends on the quality of the data which is submitted by the vaccine manufacturer
WHO's emergency use authorisation for Covaxin further delayed: Sources
The Strategic Advisory Group of Expert on Immunization (SAGE) will be meeting on October 5 on EUA to Covaxin
Bharat Biotech completes phase 2/3 trials of Covaxin for children under 18 years
On the production levels of Covaxin, Ella said 100 million doses per month can be possible
WHO Experts' Group to take a call on EUL for Covaxin on October 6
Bharat Biotech is expected to give a presentation on the Vaccine's safety and efficacy data of clinical trials
Bharat Biotech awaits feedback from WHO for Covaxin EUL
Rolling data allows the WHO to start its review right away, as information continues to come in, to accelerate the overall review process
'Number of people who got at least one dose of COVID jab in India highest in world'
Presently, about 60.7 per cent of the adult population in the country has received at least one dose of COVID-19 vaccine, the ministry said
How tech can help India reach vaccine goals and slow down its COVID-19 disaster
India’s vaccine chain has to protect against contamination before vaccines arrive, using tamper-proof seals and a transparent supply chain
India logs 45,083 new COVID-19 cases
The death toll has climbed to 4,37,830 with 460 fresh fatalities
ICMR study in Chennai shows vaccination reduces mortality due to Delta variant
The prevalence of the Delta variant or B.1.617.2 was not different between the vaccinated and un-vaccinated groups